See today's BioWorld Asia
To read the full story, subscribe or sign in.

Adlai Nortye raises $97.5M from Nasdaq IPO, private placement

Oct. 4, 2023
By Marian (YoonJee) Chu
Cancer biotech Adlai Nortye Ltd. raised $57.5 million from its U.S. IPO on Nasdaq and $40 million from a concurrent private placement, ringing up $97.5 million in funding to develop its combo immunotherapy pipeline.
BioWorld Asia Financings Cancer IPO Asia-Pacific China